Sarepta Therapeutics, Inc.
SRPT
Revenue
360.55M
▲1.06M▲0.2960%
3 Months ChangeAssets
3.42B
▲199.87M▲6.20%
3 Months ChangeLiabilities
2.35B
▲84.00M▲3.71%
3 Months ChangeFree Cash Flow
-274.52M
▼-55.64M▼-25.42%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0000950170-24-106619
2024-08-07
Form 10-Q
ID: 0000950170-24-092720
2024-06-07
Form 8-K
ID: 0001193125-24-157458
2024-05-01
Form 10-Q
ID: 0000950170-24-051234
2024-01-08
Form 8-K
ID: 0000950170-24-002822
2023-11-01
Form 10-Q
ID: 0000950170-23-057414
2023-08-02
Form 10-Q
ID: 0000950170-23-037125
2023-06-22
Form 8-K
ID: 0000950170-23-029438
2023-06-22
Form 8-K
ID: 0000950170-23-029354
2023-06-09
Form 8-K
ID: 0000950170-23-027276